PT2182960E - Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele - Google Patents

Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele Download PDF

Info

Publication number
PT2182960E
PT2182960E PT87948089T PT08794808T PT2182960E PT 2182960 E PT2182960 E PT 2182960E PT 87948089 T PT87948089 T PT 87948089T PT 08794808 T PT08794808 T PT 08794808T PT 2182960 E PT2182960 E PT 2182960E
Authority
PT
Portugal
Prior art keywords
creasing
sagging
formulations
compounds
methods
Prior art date
Application number
PT87948089T
Other languages
English (en)
Inventor
Jack Dejovin
Original Assignee
Galderma Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Lab Inc filed Critical Galderma Lab Inc
Publication of PT2182960E publication Critical patent/PT2182960E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT87948089T 2007-07-27 2008-07-28 Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele PT2182960E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95229807P 2007-07-27 2007-07-27

Publications (1)

Publication Number Publication Date
PT2182960E true PT2182960E (pt) 2014-06-11

Family

ID=40304650

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87948089T PT2182960E (pt) 2007-07-27 2008-07-28 Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele

Country Status (10)

Country Link
US (3) US20090060852A1 (pt)
EP (1) EP2182960B1 (pt)
CY (1) CY1115130T1 (pt)
DK (1) DK2182960T3 (pt)
ES (1) ES2463717T3 (pt)
HR (1) HRP20140397T1 (pt)
PL (1) PL2182960T3 (pt)
PT (1) PT2182960E (pt)
SI (1) SI2182960T1 (pt)
WO (1) WO2009017705A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
PT2182960E (pt) 2007-07-27 2014-06-11 Galderma Lab Inc Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele
BRPI0819075A2 (pt) 2007-11-16 2014-10-07 Vicept Therapeutics Inc Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
EP2262469A4 (en) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc SKIN CARE COMPOSITIONS AND METHODS OF USE
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2010232547A1 (en) * 2009-04-02 2011-10-27 Allergan, Inc. Hair-like shaped hydrogels for soft tissue augmentation
CA2761283A1 (en) * 2009-05-29 2010-12-02 Galderma Research & Development Combination of adrenergic receptor agonist .alpha.-1 or .alpha.-2, preferably brimonidine with fillers, preferablyhyaluronic acid
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
EP2552448B1 (en) 2010-03-26 2019-04-24 Galderma Research & Development Improved compositions comprising brimonidine for safe and effective treatment of telangiectasia
PT2552449T (pt) 2010-03-26 2017-06-12 Galderma Res & Dev Composições que compreendem brimonidina para o tratamento de eritema
US20120076738A1 (en) * 2010-09-28 2012-03-29 Michael Graeber Combination treatment for dermatological conditions
US8053427B1 (en) * 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
NO2444068T3 (pt) 2010-10-21 2014-12-20
WO2013052770A1 (en) 2011-10-05 2013-04-11 Sanders Jennifer L Methods and compositions for treating foot or hand pain
BR112015024113A2 (pt) * 2013-03-20 2017-07-18 Hoffmann La Roche derivados de uréia e seu uso como inibidores da proteína de ligação de ácido graxo (fabp)
EP3099300B1 (en) * 2014-01-29 2018-09-05 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164570A (en) * 1973-09-24 1979-08-14 David Clough Stabilized aqueous catecholamine solutions
US4285967A (en) * 1978-06-30 1981-08-25 Estee Lauder Inc. Cosmetic preparation for reducing redness of blemishes
US4256763A (en) * 1978-09-19 1981-03-17 Mchugh John E Treatment of herpes simplex infections and acne
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2648709A1 (fr) * 1989-06-23 1990-12-28 Boehringer Ingelheim France Nouvelle utilisation de derives de 1-phenyl-2-aminoethanol en tant que moyens cicatrisants
US5012797A (en) * 1990-01-08 1991-05-07 Montefiore Hospital Association Of Western Pennsylvania Method for removing skin wrinkles
US5254331A (en) * 1991-09-12 1993-10-19 Chanel, Inc. Skin cream composition
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
US5643586A (en) * 1995-04-27 1997-07-01 Perricone; Nicholas V. Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
DE29612123U1 (de) * 1996-07-11 1996-09-12 Kafl, Johann, 83730 Fischbachau Dermapermeables (hautdurchlässiges) Gel (Salbe) zur subcutanen Lipidmetabolisierung (Unterhautfettverbrennung) und Behandlung von Cellulite
US5916574A (en) * 1996-10-09 1999-06-29 Ideal Ideas, Inc. Method of treating natural poison skin conditions
US5910312A (en) * 1996-10-09 1999-06-08 Ideal Ideas, Inc. Acne treatment composition with vasoconstrictor
CN1663559B (zh) * 1998-03-11 2010-10-06 株式会社创研 皮肤健全剂
US5989528A (en) * 1998-07-30 1999-11-23 The Procter & Gamble Company Sunscreen compositions
US6444647B1 (en) * 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US20040266776A1 (en) * 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
JP2004196759A (ja) * 2002-12-18 2004-07-15 Takashi Suzuki ビタミンｋ類とビタミンｅ複合の美肌化粧料
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20050020600A1 (en) * 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20060275228A1 (en) * 2005-05-09 2006-12-07 Bissett Donald L Skin care compositions containing idebenone
US20070082070A1 (en) * 2005-10-11 2007-04-12 Stookey Evangeline L Treating skin disorders
US7252816B1 (en) * 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
PT2182960E (pt) 2007-07-27 2014-06-11 Galderma Lab Inc Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele

Also Published As

Publication number Publication date
PL2182960T3 (pl) 2014-08-29
US20110286945A1 (en) 2011-11-24
DK2182960T3 (da) 2014-05-26
EP2182960B1 (en) 2014-03-19
US8440688B2 (en) 2013-05-14
ES2463717T3 (es) 2014-05-29
EP2182960A1 (en) 2010-05-12
SI2182960T1 (sl) 2014-07-31
CY1115130T1 (el) 2016-12-14
WO2009017705A1 (en) 2009-02-05
US20130243837A1 (en) 2013-09-19
US20090060852A1 (en) 2009-03-05
EP2182960A4 (en) 2010-10-27
HRP20140397T1 (hr) 2014-06-20

Similar Documents

Publication Publication Date Title
PT2182960E (pt) Compostos, formulações e métodos para a redução das rugas, da flacidez e dos sulcos na pele
GB2463583B (en) Folding utility knife and related method
EP2222161A4 (en) QUINOXALINYL DERIVATIVES
HK1121757A1 (en) Pyrroloazacyclic derivatives, preparing method and use thereof
EP2271983A4 (en) TOOLBAR EXTENDABLE AND ADAPTABLE TO WEB SERVICES APPLICATIONS
PL2142109T3 (pl) Szablony chirurgiczne
HK1145965A1 (en) Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
EP2254710A4 (en) LOW STRENGTH ROLL FOLDING SYSTEM AND METHODS THEREOF
EP2127634A4 (en) COMPOSITION FOR SKIN OR HAIR
EP2119428A4 (en) AGENT FOR IMPROVING WAVE ONDULATIONS
IL208336A (en) Pyridazinone derivatives, drugs containing them and their uses and process for preparation
EP2211851A4 (en) LAMININS, DERIVATIVES, COMPOSITIONS CONTAINING SAME, AND METHOD FOR THEIR THERAPEUTIC USE
GB0719202D0 (en) Compositions and methods for the skin and hair
EP2114209A4 (en) FOLDING CHAIR
EP2165458A4 (en) Identity assertion
EP2298267A4 (en) DEVICE FOR PREVENTING SKIN SEPARATION AND WRINKLE
GB2461735B (en) Folding chair
EP2196122A4 (en) ROLL OF SANITARY PAPER
ZA201005306B (en) 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
AP2660A (en) 1,4-Naphthoquinone derivatives and therapeutic usethereof
IL202474A0 (en) 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
GB2447884B (en) Treatment for skin disease
HK1144093A1 (en) Sophocarpine-series derivative, and preparation method and use thereof
GB0807438D0 (en) Expanding medical collet
EP2314277A4 (en) EXTERNAL PREPARATION FOR SKIN AND WRINKLE CORRECTIVE AGENTS